KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scansource (SCSC) Asset Writedowns and Impairment (2016 - 2025)

Scansource (SCSC) has disclosed Asset Writedowns and Impairment for 17 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment fell 14.01% to $3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.0 million through Dec 2025, down 18.06% year-over-year, with the annual reading at $8.4 million for FY2025, 0.41% changed from the prior year.
  • Asset Writedowns and Impairment hit $3.7 million in Q4 2025 for Scansource, up from $1.9 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $4.2 million in Q4 2024 to a low of -$1.0 million in Q3 2021.
  • Historically, Asset Writedowns and Impairment has averaged $1.4 million across 5 years, with a median of $1.4 million in 2022.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 12737.5% in 2021 and later skyrocketed 3225.6% in 2023.
  • Year by year, Asset Writedowns and Impairment stood at $1.9 million in 2021, then crashed by 104.72% to -$92000.0 in 2022, then soared by 442.39% to $315000.0 in 2023, then surged by 1248.25% to $4.2 million in 2024, then fell by 14.01% to $3.7 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for SCSC at $3.7 million in Q4 2025, $1.9 million in Q3 2025, and $652000.0 in Q2 2025.